Preferred Label : Nusinersen;

UNII : 5Z9SP3X666;

CAS number : 1258984-36-9;

NCI Metathesaurus CUI : CL972121;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3529321/fr/spinraza-nusinersen-sodique-amyotrophie-spinale
2024
France
evaluation of the transparency committee
SPINRAZA
Nusinersen
Spinal Muscular Atrophy
muscular atrophy, spinal
nusinersen
spinal muscular atrophy, nos
nusinersen

---
https://pgtmsite.files.wordpress.com/2024/01/ad_nusinersen_pgtm_20221021_final_approbation-ce_ajustments-cs_20231130_5-1.pdf
2022
Canada
drug information
No Treatment for Diabetes
adult
muscular atrophy, spinal
hospitals, university
spinal muscular atrophy, nos
Analyzed
GDC Treatment Frequency Terminology
Spinal Muscular Atrophy
Therapy Object
nusinersen
Usage
During Treatment
Identifier
Child
Biomaterial Treatment
On Treatment
Description
Analysis
Treatment Epoch
child
child, nos
Offspring
nusinersen
Treatment Study
spinal muscular atrophies of childhood
Treatment
Treat
adulthood
Nusinersen
Legal Adult
quebec
adult children

---
https://pgtmsite.files.wordpress.com/2024/01/protocole-ad-nusinersen_2020_v-20210210_amendements-acceptes.pdf
2020
Canada
drug information
AD Regimen
nusinersen
Nusinersen
nusinersen

---
Nous contacter.
28/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.